Fatima Wong
Critical Care Medicine · Camden, NJNPI 1730506668
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.7% of it on its own, with 12 other manufacturers making up the rest. 2023 is the largest year on record at $4,873, 8.1 times the $601 reported in 2019.
Across 54 payments — averaging $108.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- GSK$290
- Boehringer Ingelheim$165
- Merck$109
- Insmed, Inc.$81
- AstraZeneca$65
- plus $186 from 7 others
What the payments were for
- Travel & lodging$1,64728%
- Food & beverage$1,18620%
- Education$3,00051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $4,938 |
| GSK | 8 | $290 |
| Boehringer Ingelheim | 7 | $165 |
| Merck | 6 | $109 |
| Insmed, Inc. | 5 | $81 |
| AstraZeneca | 4 | $65 |
| Olympus America Inc. | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Mylan Specialty L.p. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| Grifols USA, LLC | 1 | $17 |
| Circassia Inc. | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,609
- NUCALA$120
How this compares
$5,833 in reported general payments places this provider in the 85th percentile of 254 critical care medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 37 | $34,417 |
| Spiriva RespimatTiotropium Bromide | 20 | $12,179 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,227 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $7,776 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $4,791 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $2,773 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,308 |
| Budesonide | 13 | $498 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $393 |
| Pantoprazole Sodium | 11 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Symbicort | $65 | $42,19264 claims |
| Boehringer IngelheimSpiriva Respimat | $165 | $12,17920 claims |
| GSKTrelegy Ellipta | $290 | $8,22713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 254 critical care medicine providers in New Jersey.
Other critical care medicine in Camden
- R Phillip DellingerCamden$74K
- Shawana HussainCamden$19K
- Theodore PlushCamden$18K
- Stephen TrzeciakCamden$17K
- Osheen AbramianCamden$10K
- Nagendra MadisiCamden$6K
- Samson ZarbivCamden$5K
- Nathalie van der RijstCamden$3K
- Sharad PatelCamden$2K
- Robert ColeCamden$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.